| 000 | 01427 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250511233101.0 | ||
| 264 | 0 | _c19900222 | |
| 008 | 199002s 0 0 eng d | ||
| 022 | _a0022-2623 | ||
| 024 | 7 |
_a10.1021/jm00163a006 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSliskovic, D R | |
| 245 | 0 | 0 |
_aInhibitors of cholesterol biosynthesis. 2. 1,3,5-trisubstituted [2-(tetrahydro-4-hydroxy-2-oxopyran-6-yl)ethyl]pyrazoles. _h[electronic resource] |
| 260 |
_bJournal of medicinal chemistry _cJan 1990 |
||
| 300 |
_a31-8 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aChemical Phenomena |
| 650 | 0 | 4 | _aChemistry |
| 650 | 0 | 4 |
_aCholesterol _xbiosynthesis |
| 650 | 0 | 4 | _aHydroxymethylglutaryl-CoA Reductase Inhibitors |
| 650 | 0 | 4 | _aLactones |
| 650 | 0 | 4 |
_aLiver _xenzymology |
| 650 | 0 | 4 |
_aLovastatin _xanalogs & derivatives |
| 650 | 0 | 4 |
_aMevalonic Acid _xanalogs & derivatives |
| 650 | 0 | 4 | _aMolecular Conformation |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 |
_aPyrazoles _xchemical synthesis |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aRoth, B D | |
| 700 | 1 | _aWilson, M W | |
| 700 | 1 | _aHoefle, M L | |
| 700 | 1 | _aNewton, R S | |
| 773 | 0 |
_tJournal of medicinal chemistry _gvol. 33 _gno. 1 _gp. 31-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm00163a006 _zAvailable from publisher's website |
| 999 |
_c2302104 _d2302104 |
||